Biomarker for Morquio Disease (BioMorquio)
NCT01457456 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-02-13
Summary
Development of a new MS-based biomarker for the early and sensitive diagnosis of Morquio disease from plasma
Conditions
- Morquio Syndrome
- Accumulation of Mucopolysaccharides
- Morquio Syndrome A
- Morquio B Disease
Sponsors & Collaborators
-
CENTOGENE GmbH Rostock
lead INDUSTRY
Principal Investigators
-
Peter Bauer, Prof. · Centogene GmbH
Eligibility
- Min Age
- 12 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-20
- Primary Completion
- 2021-02-28
- Completion
- 2021-02-28
Countries
- Egypt
- Germany
- India
- Sri Lanka
Study Locations
More Related Trials
-
Biomarkers and Validation of Selected Outcome Measures (CMTBiomarker)
NCT03386266 ·Status: COMPLETED
-
Magnetic Resonance Spectroscopy in Acid Sphingomyelinase Deficiency
NCT05904366 ·Status: UNKNOWN ·Phase: NA
-
Clinical Database and Biobank of Patients With Inflammatory Myopathies: the MASC Project (Myositis, DNA, Serum, Cells) (MASC)
NCT04637672 ·Status: COMPLETED
-
COVID-19 Infection and Multiple Myeloma
NCT04492371 ·Status: COMPLETED
-
Multi-center Screening for Serum M Protein
NCT06750965 ·Status: NOT_YET_RECRUITING
-
Melanocortin Gene Expression in Lymphocytes of Polymyalgia Patients
NCT05681676 ·Status: COMPLETED
-
Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
NCT04419870 ·Status: RECRUITING
-
Connective Tissue Motion Measure
NCT01413997 ·Status: COMPLETED
-
Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers
NCT02596191 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)
NCT07204366 ·Status: ACTIVE_NOT_RECRUITING
-
Research on the Application and Mechanism of New Biological Probes in Biomedicine
NCT04977739 ·Status: COMPLETED
-
Stellate Ganglion Block to Treat Long COVID 19 Case Series
NCT05812209 ·Status: COMPLETED
-
Gut Microbiota in Patients With Moyamoya Disease
NCT04890782 ·Status: UNKNOWN
-
Search for Diagnostic and Prognostic Biomarkers in Systemic Sclerosis and Inflammatory Myopathies
NCT04917705 ·Status: RECRUITING ·Phase: NA
-
Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.
NCT06489613 ·Status: NOT_YET_RECRUITING
-
Application of Biomarkers in Neurological Diseases
NCT05881226 ·Status: RECRUITING
-
Study on the Antibody Level Against SARS-CoV-2 （COVID-19）in Dazhu County in 2023
NCT05758675 ·Status: UNKNOWN
-
GDF-15 as a Biomarker for Mitochondrial Disease
NCT02745938 ·Status: COMPLETED
-
LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions
NCT05293366 ·Status: RECRUITING
-
Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy
NCT06690593 ·Status: RECRUITING
-
Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease
NCT07049588 ·Status: RECRUITING ·Phase: NA
-
Development and Validation of Multi-nuclear Magnetic Resonance Imaging and Spectroscopy for Whole Body Human Applications
NCT02663362 ·Status: RECRUITING
-
Multispectral Optoacustic Imaging in Patients With Myositis
NCT06966739 ·Status: COMPLETED
-
Comprehensive Imaging Exam of Convalesced COVID-19 Patients
NCT05920616 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Correlation Between Intestinal Microbiota, Inflamatory Biomarkers, Intestinal Morphology, Hepatic Fibrosis Degree and Vascular Reactivity.
NCT03178006 ·Status: COMPLETED